Unrelated Cord Blood Transplantation and Post-transplant Cyclophosphamide

Overview

Journal Haematologica

Specialty Hematology

Date 2018 Dec 22

PMID 30573505

Citations 5

Authors

Andrea Bacigalupo

Simona Sica

Luca Laurenti

Federica Sora

Sabrina Giammarco

Elisabetta Metafuni

Idanna Innocenti

Francesco Autore

Luciana Teofili

Maria Bianchi

Patrizia Chiusolo

Affiliations

Soon will be listed here.

Citing Articles

Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning.

Wagner J, Ballen K, Zhang M, Allbee-Johnson M, Karanes C, Milano F Blood Adv. 2021; 5(20):4064-4072.

PMID: 34461630 PMC: 8945645. DOI: 10.1182/bloodadvances.2021004462.

Allogeneic stem cell transplantation with omidubicel in sickle cell disease.

Parikh S, Brochstein J, Galamidi E, Schwarzbach A, Kurtzberg J Blood Adv. 2021; 5(3):843-852.

PMID: 33560399 PMC: 7876871. DOI: 10.1182/bloodadvances.2020003248.

Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant.

Solomon S, Martin A, Zhang M, Ballen K, Bashey A, Battiwalla M Biol Blood Marrow Transplant. 2020; 26(10):1930-1936.

PMID: 32649981 PMC: 7530013. DOI: 10.1016/j.bbmt.2020.06.029.

Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR.

Fatobene G, Rocha V, Martin A, Hamadani M, Robinson S, Bashey A J Clin Oncol. 2020; 38(14):1518-1526.

PMID: 32031876 PMC: 7213591. DOI: 10.1200/JCO.19.02408.

Optimizing cord blood selection.

Ruggeri A Hematology Am Soc Hematol Educ Program. 2019; 2019(1):522-531.

PMID: 31808851 PMC: 6913431. DOI: 10.1182/hematology.2019000056.

References

Kurita N, Gosho M, Yokoyama Y, Kato T, Obara N, Sakata-Yanagimoto M . A phase I/II trial of intrabone marrow cord blood transplantation and comparison of the hematological recovery with the Japanese nationwide database. Bone Marrow Transplant. 2017; 52(4):574-579. DOI: 10.1038/bmt.2016.319. View

Admiraal R, Lindemans C, van Kesteren C, Bierings M, Versluijs A, Nierkens S . Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation. Blood. 2016; 128(23):2734-2741. DOI: 10.1182/blood-2016-06-721936. View

Luznik L, ODonnell P, Symons H, Chen A, Leffell M, Zahurak M . HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant. 2008; 14(6):641-50. PMC: 2633246. DOI: 10.1016/j.bbmt.2008.03.005. View

Frassoni F, Gualandi F, Podesta M, Raiola A, Ibatici A, Piaggio G . Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol. 2008; 9(9):831-9. DOI: 10.1016/S1470-2045(08)70180-3. View

Michel G, Galambrun C, Sirvent A, Pochon C, Bruno B, Jubert C . Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome. Blood. 2016; 127(26):3450-7. DOI: 10.1182/blood-2016-01-694349. View

Wagner Jr J, Eapen M, Carter S, Wang Y, Schultz K, Wall D . One-unit versus two-unit cord-blood transplantation for hematologic cancers. N Engl J Med. 2014; 371(18):1685-94. PMC: 4257059. DOI: 10.1056/NEJMoa1405584. View

Paviglianiti A, Dalle J, Ayas M, Boelens J, Volt F, Iori A . Low Body Mass Index Is Associated with Increased Risk of Acute GVHD after Umbilical Cord Blood Transplantation in Children and Young Adults with Acute Leukemia: A Study on Behalf of Eurocord and the EBMT Pediatric Disease Working Party. Biol Blood Marrow Transplant. 2017; 24(4):799-805. DOI: 10.1016/j.bbmt.2017.12.790. View

de Koning C, Admiraal R, Nierkens S, Boelens J . Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the ugly. Stem Cell Investig. 2017; 4:38. PMC: 5460145. DOI: 10.21037/sci.2017.05.02. View

Passweg J, Baldomero H, Bader P, Bonini C, Duarte R, Dufour C . Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant. 2017; 52(6):811-817. PMC: 5467246. DOI: 10.1038/bmt.2017.34. View

10.

Chen Y, Wang T, Hemmer M, Brady C, Couriel D, Alousi A . GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes. Bone Marrow Transplant. 2016; 52(3):400-408. PMC: 5332289. DOI: 10.1038/bmt.2016.265. View

11.

Admiraal R, Nierkens S, de Witte M, Petersen E, Fleurke G, Verrest L . Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis. Lancet Haematol. 2017; 4(4):e183-e191. DOI: 10.1016/S2352-3026(17)30029-7. View

12.

Admiraal R, van Kesteren C, Jol-van der Zijde C, Lankester A, Bierings M, Egberts T . Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis. Lancet Haematol. 2015; 2(5):e194-203. DOI: 10.1016/S2352-3026(15)00045-9. View

13.

Baron F, Ruggeri A, Beohou E, Labopin M, Mohty M, Blaise D . Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT. J Hematol Oncol. 2017; 10(1):128. PMC: 5479038. DOI: 10.1186/s13045-017-0497-9. View

14.

Danby R, Rocha V . Improving engraftment and immune reconstitution in umbilical cord blood transplantation. Front Immunol. 2014; 5:68. PMC: 3932655. DOI: 10.3389/fimmu.2014.00068. View

15.

Raiola A, Dominietto A, di Grazia C, Lamparelli T, Gualandi F, Ibatici A . Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts. Biol Blood Marrow Transplant. 2014; 20(10):1573-9. DOI: 10.1016/j.bbmt.2014.05.029. View

16.

Baron F, Ruggeri A, Beohou E, Labopin M, Sanz G, Milpied N . RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMT. Oncotarget. 2016; 7(28):43027-43038. PMC: 5190005. DOI: 10.18632/oncotarget.9599. View

17.

Mehta R, Dave H, Bollard C, Shpall E . Engineering cord blood to improve engraftment after cord blood transplant. Stem Cell Investig. 2017; 4:41. PMC: 5460100. DOI: 10.21037/sci.2017.05.01. View

18.

Passweg J, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P . The EBMT activity survey: 1990-2010. Bone Marrow Transplant. 2012; 47(7):906-23. DOI: 10.1038/bmt.2012.66. View